Baltimore, Sunogel Biotechnologies, Inc. (“Sunogel” or “the Company”), a leader in deep dermal wound healing research, committed to scientific excellence and patient care has been selected as a Wellbeing track finalists at the 2017 Hello Tomorrow Global Challenge, Paris.

Dr Guoming Sun, Chief Executive Officer of Sunogel, commented:

“We are excited to be selected as a Wellbeing track finalist at the Hello Tomorrow Global Challenge. Hello Tomorrow is a worldwide renowned science & technology summit bringing together a community of actors that aims to unlock the potential of deep technologies to solve the world’s toughest challenges. To be selected among the seven finalist in the Wellbeing track demonstrates our potential. We look forward to presenting our technology.”